AR088234A1 - COMPOSITION FOR USE IN THE NAILS IN A HUMAN PATIENT - Google Patents

COMPOSITION FOR USE IN THE NAILS IN A HUMAN PATIENT

Info

Publication number
AR088234A1
AR088234A1 ARP120103701A ARP120103701A AR088234A1 AR 088234 A1 AR088234 A1 AR 088234A1 AR P120103701 A ARP120103701 A AR P120103701A AR P120103701 A ARP120103701 A AR P120103701A AR 088234 A1 AR088234 A1 AR 088234A1
Authority
AR
Argentina
Prior art keywords
composition
nails
nail
deficiency
immunomodulator
Prior art date
Application number
ARP120103701A
Other languages
Spanish (es)
Inventor
G Walt John
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of AR088234A1 publication Critical patent/AR088234A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00Manicure or pedicure preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/062Oil-in-water emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Composición para uso en las uñas en un paciente humano, que contiene un inmunomodulador, donde la composición está en una emulsión aceite-en-agua y se aplica tópicamente a las uñas del paciente. Reivindicación 1: Una composición para uso en la mejora de la salud de las uñas en un paciente humano, la composición que contiene un inmunomodulador en el que la composición está en una emulsión aceite-en- agua, y se aplica tópicamente a las uñas del paciente. Reivindicación 2: La composición de la reivindicación 1, en la que el inmunomodulador es la ciclosporina. Reivindicación 4: La composición de la reivindicación 3, en la que el anti-inflamatorio es quetorolac. Reivindicación 5: La composición de la reivindicación 1, en la que la emulsión contiene aceite de ricino y un tensioactivo. Reivindicación 6: La composición de la reivindicación 1, en la que la emulsión contiene, por lo menos, un componente seleccionado del grupo que consiste en glicerina, polisorbato 80 y carbómero. Reivindicación 7: La composición de la reivindicación 1, en la que la composición contiene 0,5% - 1,5% p/p de polisorbato 80, 0,5% - 1,5% p/p de glicerina, 0,5% -1,5% p/p de aceite de ricino, 0,05% - 0,1% p/p carbómero 1342 y manitol. Reivindicación 11: La composición de la reivindicación 1, que es útil para tratar un trastorno de la uña seleccionado del grupo que consiste de psoriasis ungueal, distrofia ungueal psoriásica, síndrome de las uñas quebradizas, incremento de la longitud y grosor de las uñas, oniquia, oniquiagriposis, oniquia trofia, onicocriptosis, onicodistrofia, onicogriposis, onicolisis, onicomadesis, onicauxis, onicomicosis, onicorrexis, tinea unguium, onicofosis, onicoptosis, paroniquia, pseudomonas, pterigián y unguis inversa pterigián, coiloniquia, hematoma subungueal, o algún otro trauma en la uña, deficiencia del ácido fólico, leuconiquia, síndrome de la patela de las uñas, melanoniquia, deficiencia de proteínas, uñas quebradizas y descamadas, uñas dañadas por metacrilato, deficiencia de la vitamina C, deficiencia de la vitamina, unguis tinea, adelgazamiento de las uñas asociada al liquen plano, enfermedad de Raynaud, sangrado asociado con la artritis reumatoide, líneas de beau, y líneas de Mee asociadas con ciertos tipos de envenenamiento.Composition for use on the nails in a human patient, which contains an immunomodulator, where the composition is in an oil-in-water emulsion and is applied topically to the patient's nails. Claim 1: A composition for use in improving the health of the nails in a human patient, the composition containing an immunomodulator in which the composition is in an oil-in-water emulsion, and is applied topically to the nails of the patient. Claim 2: The composition of claim 1, wherein the immunomodulator is cyclosporine. Claim 4: The composition of claim 3, wherein the anti-inflammatory is ketorolac. Claim 5: The composition of claim 1, wherein the emulsion contains castor oil and a surfactant. Claim 6: The composition of claim 1, wherein the emulsion contains at least one component selected from the group consisting of glycerin, polysorbate 80 and carbomer. Claim 7: The composition of claim 1, wherein the composition contains 0.5% - 1.5% w / w polysorbate 80, 0.5% - 1.5% w / w glycerin, 0.5 % -1.5% w / w castor oil, 0.05% - 0.1% w / w carbomer 1342 and mannitol. Claim 11: The composition of claim 1, which is useful for treating a nail disorder selected from the group consisting of nail psoriasis, psoriatic nail dystrophy, brittle nail syndrome, increased nail length and thickness, onychia , onychiagriposis, onychia trophy, onicocriptosis, onychodystrophy, onychromyposis, onycholysis, onychomadesis, onicauxis, onychomycosis, onychorrhexis, tinea unguium, onychophoresis, onicoptosis, paronychia, pseudomonas, pterygian or othergia, subcutaneous or other trauma in a hematomae nail, folic acid deficiency, leuconychia, nail patella syndrome, melanonychia, protein deficiency, brittle and peeling nails, methacrylate damaged nails, vitamin C deficiency, vitamin deficiency, tinea unguis, thinning of the nails associated with lichen planus, Raynaud's disease, bleeding associated with rheumatoid arthritis, d lines e beau, and Mee lines associated with certain types of poisoning.

ARP120103701A 2011-10-05 2012-10-04 COMPOSITION FOR USE IN THE NAILS IN A HUMAN PATIENT AR088234A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161543758P 2011-10-05 2011-10-05

Publications (1)

Publication Number Publication Date
AR088234A1 true AR088234A1 (en) 2014-05-21

Family

ID=47046873

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120103701A AR088234A1 (en) 2011-10-05 2012-10-04 COMPOSITION FOR USE IN THE NAILS IN A HUMAN PATIENT

Country Status (10)

Country Link
EP (1) EP2763649A2 (en)
JP (1) JP2014528447A (en)
KR (1) KR20140096048A (en)
CN (1) CN103987370A (en)
AR (1) AR088234A1 (en)
AU (1) AU2012318823A1 (en)
BR (1) BR112014008172A2 (en)
CA (1) CA2851346A1 (en)
TW (1) TW201321025A (en)
WO (1) WO2013052424A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013181339A2 (en) 2012-06-01 2013-12-05 Allergan, Inc. Cyclosporin a analogs
WO2016112321A1 (en) 2015-01-08 2016-07-14 Allergan, Inc. Cyclosporin derivatives wherein the mebmt sidechain has been cyclized

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2907460A1 (en) 1978-03-07 1979-09-13 Sandoz Ag NEW RESORBABLE GALENIC COMPOSITIONS
US5342625A (en) 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
US5474979A (en) 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
DK1163254T3 (en) 1999-02-26 2008-06-09 Univ British Columbia TRPM-2 antisense treatment
US6254860B1 (en) 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US20060008432A1 (en) * 2004-07-07 2006-01-12 Sebastiano Scarampi Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
US7288520B2 (en) * 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
EP1958638A1 (en) * 2007-02-14 2008-08-20 Polichem S.A. Use of chitosans to increase nail growth rate
CN102271700A (en) * 2009-01-08 2011-12-07 阿勒根公司 Cyclosporine compositions for enhancing nail growth

Also Published As

Publication number Publication date
CA2851346A1 (en) 2013-04-11
TW201321025A (en) 2013-06-01
AU2012318823A1 (en) 2014-04-24
KR20140096048A (en) 2014-08-04
EP2763649A2 (en) 2014-08-13
JP2014528447A (en) 2014-10-27
WO2013052424A3 (en) 2013-11-14
WO2013052424A2 (en) 2013-04-11
BR112014008172A2 (en) 2017-04-18
CN103987370A (en) 2014-08-13

Similar Documents

Publication Publication Date Title
NI202100009A (en) METHODS TO REDUCE THE NEED FOR REVASCU
BR112015032336A2 (en) personal care articles
CY1121398T1 (en) COMBINATION OF BREAKFAST AND BENZOLE PEROXIDE FOR THE TREATMENT OF ACNE DAMAGES
EP2005941A3 (en) Cellular rejuvenation compounds
ECSP13012546A (en) TOPICAL FORMULATION FOR A JAK INHIBITOR
BR112012029812A2 (en) cosmetic composition based on a supramolecular polymer and an absorbent filler
BRPI0700148A (en) low viscosity, long-lasting, cold preparation cosmetic emulsions
CO6460708A2 (en) BORINIC COMPOSITIONS
CO6231001A2 (en) STABILIZATION OF VITAMIN B12
BRPI1010369B8 (en) oil-in-water nanoemulsion cosmetic composition and use of a
BR112015005369A2 (en) usp30 inhibitors and methods for their use
CR20110219A (en) NAPHYLACTIC ACIDS
BR112014012726A2 (en) hair care compositions
BR112015019395A2 (en) compositions and methods for treating and repairing tendons
AR088234A1 (en) COMPOSITION FOR USE IN THE NAILS IN A HUMAN PATIENT
AR074765A1 (en) ENAMEL OF ONE THAT INCLUDES A DRYING OIL, A FILM FORMING POLYMER, AND A METAL SALT, AND MAKEUP PRODUCT
ES2497667T3 (en) Emulsification system for use in cosmetics
AR085048A1 (en) IMPROVED MOISTURIZING COMBINATION
AR109799A1 (en) COMPOSITION FOR HAIR TREATMENT
BRPI0706244A2 (en) cosmetic compositions, use of at least one ester and cosmetic process for the makeup and / or care of keratin skin, lips and / or fibers
ECSP15050273A (en) ORAL FORMULATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
AR097216A1 (en) COMPOSITION FOR TREATMENT AGAINST SKIN AGING
EP2223679A3 (en) Cellular rejuvenation compounds
AR056018A1 (en) A COMPOSITION TO USE ON THE SKIN
BR112014015147A2 (en) dianidrohexitol diester mixture gc

Legal Events

Date Code Title Description
FA Abandonment or withdrawal